Evidence map›Paper›PMID 25906156›Full record

ArticleCell death & disease2015

Characterization of adipocytes derived from fibro/adipogenic progenitors resident in human skeletal muscle.

N Arrighi, C Moratal, N Clément, S Giorgetti-Peraldi, P Peraldi, A Loubat, J-Y Kurzenne, C Dani, A Chopard, C A Dechesne

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 125 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Intermuscular Adipose Tissue in CKD: A Window into Muscle Quality and Health?Clinical journal of the American Society of Nephrology : CJASN · 2025
    Review
  8. Article
  9. PdgfrαGenes & diseases · 2025
    Review
  10. Review
  11. Article
  12. FAPs orchestrate homeostasis of muscle physiology and pathophysiology.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

N Arrighi1] UFR Sciences, Université Nice Sophia Antipolis, Nice F-06108, France [2] CNRS, UMR7277, F-06108 Nice, France [3] INSERM U1091, F-06108 Nice, France.
C Moratal1] UFR Sciences, Université Nice Sophia Antipolis, Nice F-06108, France [2] CNRS, UMR7277, F-06108 Nice, France [3] INSERM U1091, F-06108 Nice, France.
N Clément1] UFR Sciences, Université Nice Sophia Antipolis, Nice F-06108, France [2] CNRS, UMR7277, F-06108 Nice, France [3] INSERM U1091, F-06108 Nice, France.
S Giorgetti-Peraldi1] UFR Sciences, Université Nice Sophia Antipolis, Nice F-06108, France [2] INSERM U 1065, Mediterranean Research Centre for Molecular Medicine, Team: Cellular and Molecular Physiopathology of Obesity and Diabetes, Nice, France.
P Peraldi1] UFR Sciences, Université Nice Sophia Antipolis, Nice F-06108, France [2] CNRS, UMR7277, F-06108 Nice, France [3] INSERM U1091, F-06108 Nice, France.
A Loubat1] UFR Sciences, Université Nice Sophia Antipolis, Nice F-06108, France [2] CNRS, UMR7277, F-06108 Nice, France [3] INSERM U1091, F-06108 Nice, France.
J-Y KurzenneHôpitaux Pédiatriques de Nice CHU-Lenval, Nice, France.
C Dani1] UFR Sciences, Université Nice Sophia Antipolis, Nice F-06108, France [2] CNRS, UMR7277, F-06108 Nice, France [3] INSERM U1091, F-06108 Nice, France.
A ChopardUFR Sciences, Université Nice Sophia Antipolis, Nice F-06108, France.
C A Dechesne1] UFR Sciences, Université Nice Sophia Antipolis, Nice F-06108, France [2] CNRS, UMR7277, F-06108 Nice, France [3] INSERM U1091, F-06108 Nice, France.
Université Côte d'Azur · FRCentre National de la Recherche Scientifique · FRFondation Lenval · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A population of fibro/adipogenic but non-myogenic progenitors located between skeletal muscle fibers was recently discovered. The aim of this study was to determine the extent to which these progenitors differentiate into fully functional adipocytes. The characterization of muscle progenitor-derived adipocytes is a central issue in understanding muscle homeostasis. They are considered as being the cellular origin of intermuscular adipose tissue that develops in several pathophysiological situations. Here fibro/adipogenic progenitors were isolated from a panel of 15 human muscle biopsies on the basis of the specific cell-surface immunophenotype CD15+/PDGFRα+CD56-. This allowed investigations of their differentiation into adipocytes and the cellular functions of terminally differentiated adipocytes. Adipogenic differentiation was found to be regulated by the same effectors as those regulating differentiation of progenitors derived from white subcutaneous adipose tissue. Similarly, basic adipocyte functions, such as triglyceride synthesis and lipolysis occurred at levels similar to those observed with subcutaneous adipose tissue progenitor-derived adipocytes. However, muscle progenitor-derived adipocytes were found to be insensitive to insulin-induced glucose uptake, in association with the impairment of phosphorylation of key insulin-signaling effectors. Our findings indicate that muscle adipogenic progenitors give rise to bona fide white adipocytes that have the unexpected feature of being insulin-resistant.

Indexed as

AdipocytesAdipogenesisCell DifferentiationCells, CulturedFibroblastsHumansMuscle, SkeletalStem Cells

Identifiers

PMID25906156
PMCPMC4650547
OpenAlexW2014762278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.